review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0140-6736(97)04195-0 |
P698 | PubMed publication ID | 9250197 |
P2093 | author name string | R Klein | |
B E Klein | |||
P2860 | cites work | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 |
Blind and partial sight registration in Avon | Q33646943 | ||
Recent trends in the registration of blindness and partial sight in Leicestershire | Q33646951 | ||
Primary care physicians' practice patterns and diabetic retinopathy. Current levels of care | Q72996770 | ||
Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme | Q73031887 | ||
Two-year course of visual acuity in severe proliferative diabetic retinopathy with conventional management. Diabetic Retinopathy Vitrectomy Study (DRVS) report #1 | Q93559753 | ||
Retinopathy in young-onset diabetic patients | Q93613774 | ||
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study | Q34720231 | ||
On the pathogenesis of diabetic retinopathy. A 1990 update | Q37341764 | ||
Ophthalmologic care for persons with diabetes | Q39351759 | ||
Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians | Q39622035 | ||
The prevalence of retinopathy in the insulin-requiring diabetic patients of an English country town | Q43545672 | ||
The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy | Q43576480 | ||
Diabetic retinopathy in Mexican Americans and non-Hispanic whites | Q44037303 | ||
Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy? | Q44172288 | ||
Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota | Q45201955 | ||
Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors | Q46630670 | ||
Ophthalmic examination among adults with diagnosed diabetes mellitus. | Q50607546 | ||
The medical management of hyperglycemia over a 10-year period in people with diabetes. | Q51010800 | ||
Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in Oklahoma | Q51606566 | ||
Incidence of Diabetic Retinopathy and Relationship to Baseline Plasma Glucose and Blood Pressure | Q51626229 | ||
Photocoagulation for Diabetic Macular Edema | Q60358385 | ||
Retinopathy in Pima Indians: Relationships to Glucose Level, Duration of Diabetes, Age at Diagnosis of Diabetes, and Age at Examination in a Population with a High Prevalence of Diabetes Mellitus | Q66884948 | ||
Cost-effectiveness of alternative methods for diabetic retinopathy screening | Q67574979 | ||
A relative cost-effectiveness analysis of different methods of screening for diabetic retinopathy | Q67903084 | ||
The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate | Q68018610 | ||
Genetic Marker Associations With Proliferative Retinopathy in Persons Diagnosed With Diabetes Before 30 yr of age | Q68169143 | ||
Is menarche associated with diabetic retinopathy? | Q68550074 | ||
The relationship of puberty to diabetic retinopathy | Q68706023 | ||
Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects | Q69426099 | ||
New management concepts for timely diagnosis of diabetic retinopathy treatable by photocoagulation | Q69444229 | ||
Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? | Q69553999 | ||
Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study | Q69639684 | ||
Prevalence of diabetic complications in relation to risk factors | Q69640960 | ||
Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study | Q69749970 | ||
Association of cigarette smoking with diabetic retinopathy | Q70212747 | ||
The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years | Q70330511 | ||
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years | Q70330516 | ||
The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy | Q70760004 | ||
Cost-effectiveness of detecting and treating diabetic retinopathy | Q70880919 | ||
Relation of glycemic control to diabetic microvascular complications in diabetes mellitus | Q70880944 | ||
Visual impairment in diabetes | Q71307488 | ||
Prevalence of retinopathy and proteinuria in type 1 diabetics in Iceland | Q71467811 | ||
The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study | Q71717937 | ||
Diabetic retinopathy in Nauruans | Q71755916 | ||
Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group | Q71759102 | ||
Older-onset diabetes and lens opacities. The Beaver Dam Eye Study | Q71803736 | ||
Is cigarette smoking associated with diabetic retinopathy? | Q71816165 | ||
Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study | Q72071872 | ||
Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group | Q72174601 | ||
Standards of medical care for patients with diabetes mellitus. American Diabetes Association | Q72179968 | ||
The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus | Q72340287 | ||
Retinopathy in African Americans and whites with insulin-dependent diabetes mellitus | Q72855303 | ||
P433 | issue | 9072 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
P304 | page(s) | 197-204 | |
P577 | publication date | 1997-07-01 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Diabetic eye disease | |
P478 | volume | 350 |
Q40095379 | A randomised trial of non-mydriatic ultra-wide field retinal imaging versus usual care to screen for diabetic eye disease: rationale and protocol for the Clearsight trial. |
Q37873482 | Anti-inflammatory therapy for diabetic retinopathy. |
Q34800913 | Arginase in retinopathy |
Q36385680 | Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) Project: rationale and design |
Q74309367 | Danaparoid sodium in diabetic retinopathy |
Q41776952 | Diabetic cataract-pathogenesis, epidemiology and treatment. |
Q30771262 | Diabetic retinopathy after combined kidney-pancreas transplantation |
Q82855470 | Genetics of diabetic retinopathy |
Q43588806 | Heart rate elevation and diabetic retinopathy in patients with type 2 diabetes mellitus and normoalbuminuria |
Q37911285 | Inflammation and diabetic retinal microvascular complications |
Q34477134 | Laser refractive surgery in diabetic patients: a review of the literature |
Q33605860 | Live imaging of primary ocular vasculature formation in zebrafish |
Q74530411 | Neurovisual impairment: a frequent complication of alpha-interferon treatment in chronic viral hepatitis |
Q34516437 | Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy |
Q34669214 | Printed educational messages aimed at family practitioners fail to increase retinal screening among their patients with diabetes: a pragmatic cluster randomized controlled trial [ISRCTN72772651]. |
Q34871834 | Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population-based study |
Q73370925 | Screening for diabetic retinopathy |
Q35877208 | Systemic and Intravitreal Delivery of Dendrimers to Activated Microglia/Macrophage in Ischemia/Reperfusion Mouse Retina |
Q36412693 | The Ontario printed educational message (OPEM) trial to narrow the evidence-practice gap with respect to prescribing practices of general and family physicians: a cluster randomized controlled trial, targeting the care of individuals with diabetes a |
Q73252563 | The effect of health education on the rate of ophthalmic examinations among African Americans with diabetes mellitus |
Q34220590 | The potential of nanomedicine therapies to treat neovascular disease in the retina. |
Q35589328 | The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study |
Q28072125 | The role of Toll-like receptors in retinal ischemic diseases |
Q34280300 | Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. |
Q36929380 | Vascular endothelial growth factor in eye disease |
Search more.